Skip to content
Vectorb2b
  • Home
  • About us
    • Governance
    • Our team
    • Careers
  • Services
    • Discovery
    • Toxicology
    • Chemistry Manufacturing
    • Clinical Services
    • Functional Service Providing
    • R&D Portfolio Management Services
    • Integrated Solutions
  • Articles
  • News
  • Contacts
  • Home
  • About us
    • Governance
    • Our team
    • Careers
  • Services
    • Discovery
    • Toxicology
    • Chemistry Manufacturing
    • Clinical Services
    • Functional Service Providing
    • R&D Portfolio Management Services
    • Integrated Solutions
  • Articles
  • News
  • Contacts
VectorB2B
  • October 20, 2026

Glaucoma: evaluating retinal protection in preclinical models

  • October 6, 2026

Grant writing tips for pharma and biotech: how to build a competitive funding proposal

  • September 22, 2026

Diabetic retinopathy: evaluating therapeutic strategies in preclinical models

How preclinical models support glaucoma research and the evalua-tion of retinal protection

Glaucoma: evaluating retinal protection in preclinical models

October 20, 2026
Read More »
Pharma and biotech: 7 grant writing tips to strengthen a funding proposal

Grant writing tips for pharma and biotech: how to build a competitive funding proposal

October 6, 2026
Read More »
Diabetic retinopathy case study: evaluating retinal damage and therapeutic responses in preclinical models

Diabetic retinopathy: evaluating therapeutic strategies in preclinical models

September 22, 2026
Read More »
GLP toxicology requirements across different stages of drug development

GLP toxicology requirements: when are studies needed in drug development?

September 8, 2026
Read More »
7 common mistakes when building a regulatory strategy for clinical development

Building a regulatory strategy for clinical development: avoiding the most common mistakes

August 25, 2026
Read More »
Recombinant protein purification with ÄKTA™ systems

How do ÄKTA chromatography systems support recombinant protein purification?

August 11, 2026
Read More »
Load More
Vector B2B

Follow Us

Quick access
  • Discovery
  • Toxicology
  • Manufacturing Services
  • Clinical Services
  • Integrated Solutions
  • Careers
Contacts

Avenida da Liberdade, 258, 6.º 1250-149 Lisboa Portugal

+351 210 976 863

info@vectorb2b.com

  • Copyright © 2026
  • All rights reserved
  • Privacy policy